Stockreport

Veru Announces Meta-analysis of Body Composition Data from Older Patients with Obesity which Supports Potential for Enobosarm to Optimize Weight Loss at ObesityWeek

Veru Inc.  (VERU) 
Last veru inc. earnings: 2/12 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: verupharma.com/investors
PDF MIAMI, FL, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for p [Read more]